Brainxell, Inc.
Madison, WI
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 455 Science Dr #210, Madison, WI 53711, USA
- Website
- brainxell.com
- Founded
- 2015
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $18,725 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Stem Pharmacy | Fitchburg, WI | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Vala Sciences Inc. | San Diego, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| New York Stem Cell Foundation Inc. | New York, NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Modulo Bio, Inc. | San Diego, CA | — |
| Curi Bio Inc. | Seattle, WA | 334516 Analytical Laboratory Instrument Manufacturing |
About the company
Brainxell, Inc. is a for-profit corporate entity located in Madison, Wisconsin, specializing in the manufacturing of human neuron cells and related services for neurological disease research and drug discovery. Registered in SAM.gov since July 2015, the company provides sophisticated cellular engineering solutions, focusing on developing advanced human cell lines derived from induced pluripotent stem cells (iPSCs). Their core competency involves creating specialized neural cell types, including neurons, astrocytes, and microglia, which are critical for advancing medical research and pharmaceutical development in neurological and psychiatric disorder domains.
Through federal contract awards, Brainxell, Inc. has primarily worked with agencies within the National Institutes of Health (NIH), including the National Institute on Drug Abuse, National Center for Advancing Translational Sciences, and National Institute on Alcohol Abuse and Alcoholism. The company has received multiple purchase order contracts totaling approximately $213,240, with contract values ranging from $11,900 to $130,500. These contracts involved specialized services such as generating stable EGFP-expressing iPSC lines, differentiating iPSCs into spinal motor neurons, producing CRISPR-engineered cells, and creating differentiated neurons for evaluating neuronal infectivity of SARS-CoV-2. Most contracts were awarded without specific set-aside designations, with one small business set-aside contract noted.
Brainxell, Inc. has secured two significant federal grant awards from NIH institutes, specifically the National Institute of Mental Health and the National Institute on Aging. These Phase I SBIR grants, valued at undisclosed amounts, focus on accelerating the functional maturation of human iPSC-derived brain cells. The R43MH135527 grant aims to develop methods for rapidly generating mature astrocytes, while the R43AG073055 grant concentrates on creating mature microglia. Both grants share a common objective of improving drug discovery platforms by developing more advanced, mature human brain cell models. The research targets understanding and potentially treating neurological and psychiatric disorders, including Alzheimer's disease, by creating more sophisticated cellular screening platforms that can better represent mature human brain cell characteristics.
Quick answers
Is Brainxell, Inc. registered in SAM.gov?
Yes. Brainxell, Inc.'s SAM.gov registration is active through January 29, 2027.
What is Brainxell, Inc.'s CAGE code?
Brainxell, Inc.'s CAGE code is 7EV37, and its Unique Entity ID (UEI) is CFGFE23M73T7.
How much has Brainxell, Inc. received in federal contracts?
Federal contracts obligated $18,725 to Brainxell, Inc. in fiscal years 2023 through 2027.
What is Brainxell, Inc.'s most recent federal award?
Brainxell, Inc.'s most recent federal contract award is Brainxell, INC:1270448 [24-007322] (75N95024P00619), from National Institute on Drug Abuse (NIH), on September 16, 2024.
On GovTribe
See Brainxell, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors